Skip to main content
Clinical Trials/JPRN-jRCTs042230155
JPRN-jRCTs042230155
Recruiting
未知

Middle ear pressuretreatment by EFET01 in patients with atypical Meniere's disease

Takakura Hiromasa0 sites30 target enrollmentFebruary 19, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Atypical Meniere's disease
Sponsor
Takakura Hiromasa
Enrollment
30
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 19, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Takakura Hiromasa

Eligibility Criteria

Inclusion Criteria

  • 1\) Patient aged between 18 and 80 years old
  • 2\) Untreated patient who was diagnosed as atypical Meniere's disease based on the Clinical practice guidelines for Meniere's disease and delayed endolymphatic hydrops 2020
  • 3\) Patient who understands treatment method and procedure and is able to agree in writing of his own free will
  • 4\) Patinet who can use EFET01 correctly at home
  • 5\) Patient that conservative treatment is invalid

Exclusion Criteria

  • 1\) Patient using life support dispute
  • 2\) Patient using cardiac pacemarker and implantale defibrillator
  • 3\) Patient who has disase or injury in auricle and/or external auditory canal
  • 4\) Patient with tympanic membrane perforation
  • 5\) Patient unable to comply treatment method and procedure
  • 6\) Patient who was evaluated as ineligible person by doctor in charge

Outcomes

Primary Outcomes

Not specified

Similar Trials